{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:51:26Z","timestamp":1791305486265,"version":"4.3.1"},"reference-count":145,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":17,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universidade Santo Amaro"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Biosurfactants are promising biotechnological compounds for respiratory diseases due to their ability to act as antimicrobials, antivirals, and anti-inflammatories, as well as their capacity to reduce pulmonary surface tension.\n                    <jats:italic>In vitro<\/jats:italic>\n                    evidence shows that molecules such as surfactin, rhamnolipids, sophorolipids, and MELs can partially mimic natural pulmonary surfactant, promote alveolar stabilization, and improve respiratory mechanics. Furthermore, these compounds modulate essential inflammatory pathways, including NF-\u03baB, MAPK, and inflammasomes (NLRP3 and AIM2), leading to decreased production of the pro-inflammatory cytokines IL-1\u03b2, TNF-\u03b1, and IL-6. Activity against\n                    <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\n                    ,\n                    <jats:italic>Staphylococcus aureus<\/jats:italic>\n                    ,\n                    <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n                    , respiratory fungi, and enveloped viruses support their use as therapeutic agents in infectious or inflammatory conditions of the respiratory tract. Despite their potential, several challenges persist, particularly the high production costs, difficulties in structural standardization, the limited stability of inhalable forms, and the lack of clinical trials evaluating safety and efficacy in humans. The development of more advanced disease prediction models, such as pulmonary organoids and \"lung-on-a-chip\" systems, emerges as an essential path for translational evaluation. Thus, although many obstacles remain, this body of evidence demonstrates that biosurfactants represent an innovative and promising platform for improving lung function or modulating inflammatory processes in various respiratory diseases.\n                  <\/jats:p>","DOI":"10.1007\/s11095-026-04202-4","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T21:30:29Z","timestamp":1789767029000},"page":"3035-3056","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Biosurfactant-Based Interventions for Improving Lung Function and Controlling Inflammation"],"prefix":"10.1007","volume":"43","author":[{"given":"Nathalia Marton","family":"Sant\u2019Ana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4138-8040","authenticated-orcid":false,"given":"Paula","family":"Rezende-Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"key":"4202_CR1","doi-asserted-by":"publisher","unstructured":"Bush A, Byrnes CA, Chan KC, Chang AB, Ferreira JC, Holden KA, et al. Social determinants of respiratory health from birth: still of concern in the 21st century? Eur Respir Rev. 2024;33(172). https:\/\/doi.org\/10.1183\/16000617.0222-2023.","DOI":"10.1183\/16000617.0222-2023"},{"key":"4202_CR2","unstructured":"World Health Organization. World Health Organization [Internet]. 2024. Chronic obstructive pulmonary disease (COPD). Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/chronic-obstructive-pulmonary-disease-(copd). Accessed 10 Dec 2025."},{"issue":"12","key":"4202_CR3","doi-asserted-by":"publisher","first-page":"E2346598","DOI":"10.1001\/jamanetworkopen.2023.46598","volume":"6","author":"E Boers","year":"2023","unstructured":"Boers E, Barrett M, Su JG, Benjafield AV, Sinha S, Kaye L, et al. Global Burden of Chronic Obstructive Pulmonary Disease Through 2050. JAMA Netw Open. 2023;6(12):E2346598. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.46598.","journal-title":"JAMA Netw Open"},{"key":"4202_CR4","unstructured":"World Health Organization. World Health Organization [Internet]. 2024. Asthma. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/asthma. Accessed 12 Dec 2025."},{"key":"4202_CR5","doi-asserted-by":"publisher","unstructured":"Pitrez PM. The challenges of asthma care in low- and middle-income countries\u202f: what \u2019 s next\u202f? J Bras Pneumol. 2023;49(3):e20230215. https:\/\/doi.org\/10.36416\/1806-3756\/e20230215.","DOI":"10.36416\/1806-3756\/e20230215"},{"key":"4202_CR6","doi-asserted-by":"publisher","unstructured":"The Global Asthma Report 2022 [Internet]. 2022. p. 1104. Int J Tuberc Lung Dis. Available from: https:\/\/doi.org\/10.5588\/ijtld.22.1010.","DOI":"10.5588\/ijtld.22.1010"},{"issue":"3","key":"4202_CR7","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1183\/09031936.00185114","volume":"46","author":"J Hutchinson","year":"2015","unstructured":"Hutchinson J, Fogarty A, Hubbard R, McKeever T. Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review. Eur Respir J. 2015;46(3):795\u2013806. https:\/\/doi.org\/10.1183\/09031936.00185114.","journal-title":"Eur Respir J"},{"key":"4202_CR8","unstructured":"United Nations International Children\u2019s Emergency Fund. What you need to know about air pollution [Internet]. Available from: https:\/\/www.unicef.org\/parenting\/emergencies\/air-pollution. Accessed 12 Dec 2025."},{"issue":"23","key":"4202_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jcm14238557","volume":"14","author":"D Afrose","year":"2025","unstructured":"Afrose D, R\u00f8nn CP, Ekl\u00f6f J, Vognsen AK, T\u00f8nnesen LL, Bertelsen BB, et al. Inhaled Corticosteroid Use and Risk of Haemophilus influenzae Isolation in Patients with Bronchiectasis: A Retrospective Cohort Study. J Clin Med. 2025;14(23):1\u201317. https:\/\/doi.org\/10.3390\/jcm14238557.","journal-title":"J Clin Med"},{"key":"4202_CR10","doi-asserted-by":"publisher","unstructured":"Mohammednoor M, Mubarak Osman AME, Hamad S, Abdelhalim Ismail FI, Elsharief Mohammed Elamien MEY, Mohamed Gamareldin EE, et al. Impact of Inhaled Corticosteroids on Osteoporosis in Chronic Obstructive Pulmonary Disease (COPD): A Systematic Review. Cureus. 2025. https:\/\/doi.org\/10.7759\/cureus.89201.","DOI":"10.7759\/cureus.89201"},{"issue":"9","key":"4202_CR11","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1164\/rccm.202112-2745OC","volume":"206","author":"MC Peters","year":"2022","unstructured":"Peters MC, Schiebler ML, Cardet JC, Johansson MW, Sorkness R, DeBoer MD, et al. The Impact of Insulin Resistance on Loss of Lung Function and Response to Treatment in Asthma. Am J Respir Crit Care Med. 2022;206(9):1096\u2013106. https:\/\/doi.org\/10.1164\/rccm.202112-2745OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"4202_CR12","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/j.rmed.2005.11.020","volume":"100","author":"R Dahl","year":"2006","unstructured":"Dahl R. Systemic side effects of inhaled corticosteroids in patients with asthma. Respir Med. 2006;100(8):1307\u201317. https:\/\/doi.org\/10.1016\/j.rmed.2005.11.020.","journal-title":"Respir Med"},{"issue":"4","key":"4202_CR13","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1002\/med.21476","volume":"38","author":"P Mlad\u011bnka","year":"2018","unstructured":"Mlad\u011bnka P, Applov\u00e1 L, Pato\u010dka J, Costa VM, Remiao F, Pourov\u00e1 J, et al. Comprehensive review of cardiovascular toxicity of drugs and related agents. Med Res Rev. 2018;38(4):1332\u2013403. https:\/\/doi.org\/10.1002\/med.21476.","journal-title":"Med Res Rev"},{"issue":"5","key":"4202_CR14","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.rmed.2004.10.014","volume":"99","author":"S Haney","year":"2005","unstructured":"Haney S, Hancox RJ. Rapid onset of tolerance to beta-agonist bronchodilation. Respir Med. 2005;99(5):566\u201371. https:\/\/doi.org\/10.1016\/j.rmed.2004.10.014.","journal-title":"Respir Med"},{"key":"4202_CR15","doi-asserted-by":"publisher","unstructured":"Marijic P, Schwarzkopf L, Schwettmann L, Ruhnke T, Trudzinski F, Kreuter M. Pirfenidone vs. nintedanib in patients with idiopathic pulmonary fibrosis: a retrospective cohort study. Respir Res. 2021;22(1):1\u201311. https:\/\/doi.org\/10.1186\/s12931-021-01857-y.","DOI":"10.1186\/s12931-021-01857-y"},{"issue":"February","key":"4202_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2024.1309712","volume":"15","author":"KM Liao","year":"2024","unstructured":"Liao KM, Chen CY. Risk of potential hepatotoxicity from pirfenidone or nintedanib in patients with idiopathic pulmonary fibrosis: results of a retrospective analysis of a large insurance database in Taiwan. Front Pharmacol. 2024;15(February):1\u201310. https:\/\/doi.org\/10.3389\/fphar.2024.1309712.","journal-title":"Front Pharmacol"},{"issue":"5","key":"4202_CR17","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.chest.2018.06.019","volume":"154","author":"AK Guitor","year":"2018","unstructured":"Guitor AK, Wright GD. Antimicrobial Resistance and Respiratory Infections. Chest. 2018;154(5):1202\u201312. https:\/\/doi.org\/10.1016\/j.chest.2018.06.019.","journal-title":"Chest"},{"issue":"3","key":"4202_CR18","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","volume":"18","author":"E Tacconelli","year":"2018","unstructured":"Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18(3):318\u201327. https:\/\/doi.org\/10.1016\/S1473-3099(17)30753-3.","journal-title":"Lancet Infect Dis"},{"key":"4202_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10092064","author":"K Thomsen","year":"2022","unstructured":"Thomsen K, H\u00f8iby N, Jensen P\u00d8, Ciofu O, Moser C. Immune response to biofilm growing pulmonary Pseudomonas aeruginosa infection. Biomedicines. 2022. https:\/\/doi.org\/10.3390\/biomedicines10092064.","journal-title":"Biomedicines"},{"issue":"5","key":"4202_CR20","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/ptj\/75.5.397","volume":"75","author":"LP Cahalin","year":"1995","unstructured":"Cahalin LP, Sadowsky HS. Pulmonary medications. Phys Ther. 1995;75(5):397\u2013414. https:\/\/doi.org\/10.1093\/ptj\/75.5.397.","journal-title":"Phys Ther"},{"issue":"2","key":"4202_CR21","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00253-010-2589-0","volume":"87","author":"IM Banat","year":"2010","unstructured":"Banat IM, Franzetti A, Gandolfi I, Bestetti G, Martinotti MG, Fracchia L, et al. Microbial biosurfactants production, applications and future potential. Appl Microbiol Biotechnol. 2010;87(2):427\u201344. https:\/\/doi.org\/10.1007\/s00253-010-2589-0.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"12","key":"4202_CR22","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.tips.2013.10.002","volume":"34","author":"EJ Gudi\u00f1a","year":"2013","unstructured":"Gudi\u00f1a EJ, Rangarajan V, Sen R, Rodrigues LR. Potential therapeutic applications of biosurfactants. Trends Pharmacol Sci. 2013;34(12):667\u201375. https:\/\/doi.org\/10.1016\/j.tips.2013.10.002.","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"4202_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00203-025-04555-1","volume":"208","author":"D Datta","year":"2026","unstructured":"Datta D, Bhattacharjee S. Biosurfactants as novel antibiofilm agents: mechanisms, biomedical applications, and applications in biofilm-associated infections. Arch Microbiol. 2026;208(1):1\u201335. https:\/\/doi.org\/10.1007\/s00203-025-04555-1.","journal-title":"Arch Microbiol"},{"issue":"June","key":"4202_CR24","doi-asserted-by":"publisher","first-page":"125887","DOI":"10.1016\/j.ijpharm.2025.125887","volume":"681","author":"F Sultan","year":"2025","unstructured":"Sultan F, Maji D, Phatake RS, Kumar K. Pharmaceutical applications of microbial biosurfactants. Int J Pharm. 2025;681(June):125887. https:\/\/doi.org\/10.1016\/j.ijpharm.2025.125887.","journal-title":"Int J Pharm"},{"issue":"1","key":"4202_CR25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s10989-024-10586-x","volume":"30","author":"MA Bejeshk","year":"2024","unstructured":"Bejeshk MA, Rajizadeh MA, Yari A, Bagheri F, Najafipour H, Dehghannoudeh G, et al. Lipopeptide biosurfactant produced by Acinetobacter junii B6 attenuates lung inflammatory, oxidative, and histopathological alterations due to asthma in rats. Int J Pept Res Ther. 2024;30(1):3\u20135. https:\/\/doi.org\/10.1007\/s10989-024-10586-x.","journal-title":"Int J Pept Res Ther"},{"issue":"5556","key":"4202_CR26","first-page":"1","volume":"27","author":"WY Cho","year":"2022","unstructured":"Cho WY, Ng JF, Yap WH. Sophorolipids \u2014 Bio-Based Antimicrobial Formulating Agents. Molecules. 2022;27(5556):1\u201324.","journal-title":"Molecules"},{"issue":"2","key":"4202_CR27","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1007\/s10753-014-9986-y","volume":"38","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Liu C, Dong B, Ma X, Hou L, Cao X, et al. Anti-inflammatory Activity and Mechanism of Surfactin in Lipopolysaccharide-Activated Macrophages. Inflammation. 2015;38(2):756\u201364. https:\/\/doi.org\/10.1007\/s10753-014-9986-y.","journal-title":"Inflammation"},{"issue":"2","key":"4202_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10532-025-10121-9","volume":"36","author":"N Sharma","year":"2025","unstructured":"Sharma N, Ahlawat YK, Sharma AJ, Chamoli N, Thakur M, Sharma A, et al. A comprehensive review on microbial production and significant applications of multifunctional biomolecules: biosurfactants. Biodegradation. 2025;36(2):1\u201323. https:\/\/doi.org\/10.1007\/s10532-025-10121-9.","journal-title":"Biodegradation"},{"issue":"7","key":"4202_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/biot.201600561","volume":"12","author":"M Henkel","year":"2017","unstructured":"Henkel M, Geissler M, Weggenmann F, Hausmann R. Production of microbial biosurfactants: status quo of rhamnolipid and surfactin towards large-scale production. Biotechnol J. 2017;12(7):1\u201310. https:\/\/doi.org\/10.1002\/biot.201600561.","journal-title":"Biotechnol J"},{"issue":"8","key":"4202_CR30","doi-asserted-by":"publisher","first-page":"870","DOI":"10.21577\/0103-5053.20220074","volume":"33","author":"FG Barbosa","year":"2022","unstructured":"Barbosa FG, Ribeaux DR, Rocha T, Costa RAM, Guzm\u00e1n RR, Marcelino PRF, et al. Biosurfactants: Sustainable and Versatile Molecules. J Braz Chem Soc. 2022;33(8):870\u201393. https:\/\/doi.org\/10.21577\/0103-5053.20220074.","journal-title":"J Braz Chem Soc"},{"issue":"5","key":"4202_CR31","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1007\/s00253-010-2498-2","volume":"86","author":"AM Abdel-Mawgoud","year":"2010","unstructured":"Abdel-Mawgoud AM, L\u00e9pine F, D\u00e9ziel E. Rhamnolipids: Diversity of structures, microbial origins and roles. Appl Microbiol Biotechnol. 2010;86(5):1323\u201336. https:\/\/doi.org\/10.1007\/s00253-010-2498-2.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"4","key":"4202_CR32","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1089\/ind.2014.0003","volume":"10","author":"M Irfan-Maqsood","year":"2014","unstructured":"Irfan-Maqsood M, Seddiq-Shams M. Rhamnolipids: Well-Characterized Glycolipids with Potential Broad Applicability as Biosurfactants. Ind Biotechnol. 2014;10(4):285\u201391. https:\/\/doi.org\/10.1089\/ind.2014.0003.","journal-title":"Ind Biotechnol"},{"issue":"2","key":"4202_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7717\/peerj.18981","volume":"13","author":"SSA Kabeil","year":"2025","unstructured":"Kabeil SSA, Darwish AMG, Abdelgalil SA, Shamseldin A, Salah A, Taha HAIM, et al. Rhamnolipids bio-production and miscellaneous applications towards green technologies: a literature review. PeerJ. 2025;13(2):1\u201338. https:\/\/doi.org\/10.7717\/peerj.18981.","journal-title":"PeerJ"},{"issue":"1","key":"4202_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12934-020-01497-9","volume":"20","author":"P Thakur","year":"2021","unstructured":"Thakur P, Saini NK, Thakur VK, Gupta VK, Saini RV, Saini AK. Rhamnolipid the Glycolipid Biosurfactant: Emerging trends and promising strategies in the field of biotechnology and biomedicine. Microb Cell Fact. 2021;20(1):1\u201315. https:\/\/doi.org\/10.1186\/s12934-020-01497-9.","journal-title":"Microb Cell Fact"},{"issue":"February","key":"4202_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2022.824664","volume":"13","author":"R Zhang","year":"2022","unstructured":"Zhang R, Shi X, Chen Y, Liu J, Wu Y, Xu Y. Multi-omics revealed the protective effects of rhamnolipids in lipopolysaccharide challenged broilers. Front Immunol. 2022;13(February):1\u201315. https:\/\/doi.org\/10.3389\/fimmu.2022.824664.","journal-title":"Front Immunol"},{"issue":"3","key":"4202_CR36","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/0006-291X(68)90503-2","volume":"31","author":"K Arima","year":"1968","unstructured":"Arima K, Kakinuma A, Tamura G. Surfactin, a crystalline peptidelipid surfactant produced by Bacillus subtilis: Isolation, characterization and its inhibition of fibrin clot formation. Biochem Biophys Res Commun. 1968;31(3):488\u201394. https:\/\/doi.org\/10.1016\/0006-291X(68)90503-2.","journal-title":"Biochem Biophys Res Commun"},{"key":"4202_CR37","doi-asserted-by":"publisher","unstructured":"Peypoux F, Bonmatin JM, Wallach J. Recent trends in the biochemistry of surfactin. Appl Microbiol Biotechnol. 1999;51(5):553\u201363. https:\/\/doi.org\/10.1007\/s002530051432.","DOI":"10.1007\/s002530051432"},{"key":"4202_CR38","doi-asserted-by":"publisher","unstructured":"Gudi\u00f1a EJ, Teixeira JA, Rodrigues LR. Biosurfactants produced by marine microorganisms with therapeutic applications. Mar Drugs. 2016;14(2). https:\/\/doi.org\/10.3390\/md14020038","DOI":"10.3390\/md14020038"},{"key":"4202_CR39","doi-asserted-by":"publisher","unstructured":"Wu YS, Ngai SC, Goh BH, Chan KG, Lee LH, Chuah LH. Anticancer activities of surfactin potential application of nanotechnology assisted surfactin delivery. Front Pharmacol. 2017;8(OCT):1\u201322. https:\/\/doi.org\/10.3389\/fphar.2017.00761.","DOI":"10.3389\/fphar.2017.00761"},{"issue":"2","key":"4202_CR40","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1007\/s10753-014-9986-y","volume":"38","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Liu C, Dong B, Ma X, Hou L, Cao X, et al. Anti-inflammatory activity and mechanism of surfactin in lipopolysaccharide-activated macrophages. Inflammation. 2015;38(2):756\u201364. https:\/\/doi.org\/10.1007\/s10753-014-9986-y.","journal-title":"Inflammation"},{"issue":"11","key":"4202_CR41","doi-asserted-by":"publisher","first-page":"4691","DOI":"10.1007\/s00253-013-4858-1","volume":"97","author":"T Morita","year":"2013","unstructured":"Morita T, Fukuoka T, Imura T, Kitamoto D. Production of mannosylerythritol lipids and their application in cosmetics. Appl Microbiol Biotechnol. 2013;97(11):4691\u2013700. https:\/\/doi.org\/10.1007\/s00253-013-4858-1.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"3","key":"4202_CR42","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1263\/jbb.94.187","volume":"94","author":"D Kitamoto","year":"2002","unstructured":"Kitamoto D, Isoda H, Nakahara T. Functions and Potential Applications of Glycolipid Biosurfactants \u2014 from Energy-Saving Materials to Gene Delivery Carriers \u2014. J Biosci Bioeng. 2002;94(3):187\u2013201. https:\/\/doi.org\/10.1263\/jbb.94.187.","journal-title":"J Biosci Bioeng"},{"issue":"6","key":"4202_CR43","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1007\/s00253-020-10354-z","volume":"104","author":"ALS Coelho","year":"2020","unstructured":"Coelho ALS, Feuser PE, Carciofi BAM, de Andrade CJ, de Oliveira D. Mannosylerythritol lipids: antimicrobial and biomedical properties. Appl Microbiol Biotechnol. 2020;104(6):2297\u2013318. https:\/\/doi.org\/10.1007\/s00253-020-10354-z.","journal-title":"Appl Microbiol Biotechnol"},{"key":"4202_CR44","doi-asserted-by":"publisher","unstructured":"McMahon AMB, Twigg MS, Marchant R, Banat IM. The Application of Glycolipid-Type Microbial Biosurfactants as Active Pharmaceutical Ingredients for the Treatment and Prevention of Cancer. Pharmaceuticals. 2025;18(5). https:\/\/doi.org\/10.3390\/ph18050676","DOI":"10.3390\/ph18050676"},{"issue":"4","key":"4202_CR45","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.procbio.2011.01.010","volume":"46","author":"INA Van Bogaert","year":"2011","unstructured":"Van Bogaert INA, Zhang J, Soetaert W. Microbial synthesis of sophorolipids. Process Biochem. 2011;46(4):821\u201333. https:\/\/doi.org\/10.1016\/j.procbio.2011.01.010.","journal-title":"Process Biochem"},{"key":"4202_CR46","doi-asserted-by":"publisher","unstructured":"Van Bogaert INA, Saerens K, De Muynck C, Develter D, Soetaert W, Vandamme EJ. Microbial production and application of sophorolipids. Applied Microbiology and Biotechnology. 2007. p. 23\u201334. https:\/\/doi.org\/10.1007\/s00253-007-0988-7","DOI":"10.1007\/s00253-007-0988-7"},{"key":"4202_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27175556","author":"WY Cho","year":"2022","unstructured":"Cho WY, Ng JF, Yap WH, Goh BH. Sophorolipids\u2014bio-based antimicrobial formulating agents for applications in food and health. Molecules. 2022. https:\/\/doi.org\/10.3390\/molecules27175556.","journal-title":"Molecules"},{"issue":"5","key":"4202_CR48","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1134\/S0003683823050174","volume":"59","author":"Y Wang","year":"2023","unstructured":"Wang Y, Chen J, Liu X. A review on antimicrobial activity, anti-biofilm and synergistic effects of sophorolipids since their discovery. Appl Biochem Microbiol. 2023;59(5):580\u201396. https:\/\/doi.org\/10.1134\/S0003683823050174.","journal-title":"Appl Biochem Microbiol"},{"key":"4202_CR49","doi-asserted-by":"publisher","unstructured":"da Fontoura ICC, Saikawa GIA, Silveira VAI, Pan NC, Amador IR, Baldo C, et al. Antibacterial activity of sophorolipids from Candida bombicola against human pathogens. Brazilian Archives of Biology and Technology. 2020;63:1\u201310. https:\/\/doi.org\/10.1590\/1678-4324-2020180568.","DOI":"10.1590\/1678-4324-2020180568"},{"key":"4202_CR50","doi-asserted-by":"publisher","unstructured":"Singh SB, Kuniyal K, Rawat A, Bisht A, Shah V, Daverey A. Sophorolipids as anticancer agents: progress and challenges. Discover Oncology. 2025;16(1). https:\/\/doi.org\/10.1007\/s12672-025-02303-x.","DOI":"10.1007\/s12672-025-02303-x"},{"issue":"2","key":"4202_CR51","doi-asserted-by":"publisher","first-page":"9550","DOI":"10.1080\/21655979.2021.1997261","volume":"12","author":"A Daverey","year":"2021","unstructured":"Daverey A, Dutta K, Joshi S, Daverey A. Sophorolipid: a glycolipid biosurfactant as a potential therapeutic agent against COVID-19. Bioengineered. 2021;12(2):9550\u201360. https:\/\/doi.org\/10.1080\/21655979.2021.1997261.","journal-title":"Bioengineered"},{"issue":"4","key":"4202_CR52","doi-asserted-by":"publisher","first-page":"391","DOI":"10.7150\/ntno.57675","volume":"5","author":"S Naz","year":"2021","unstructured":"Naz S, Banerjee T, Totsingan F, Woody K, Gross RA, Santra S. Therapeutic efficacy of lactonic sophorolipids: nanoceria-assisted combination therapy of nsclc using hdac and hsp90 inhibitors. Nanotheranostics. 2021;5(4):391\u2013404. https:\/\/doi.org\/10.7150\/ntno.57675.","journal-title":"Nanotheranostics"},{"issue":"8","key":"4202_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11274-022-03323-3","volume":"38","author":"X Chen","year":"2022","unstructured":"Chen X, Lu Y, Shan M, Zhao H, Lu Z, Lu Y. A mini-review: mechanism of antimicrobial action and application of surfactin. World J Microbiol Biotechnol. 2022;38(8):1\u201310. https:\/\/doi.org\/10.1007\/s11274-022-03323-3.","journal-title":"World J Microbiol Biotechnol"},{"issue":"5","key":"4202_CR54","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1111\/1751-7915.13297","volume":"11","author":"Y Maeng","year":"2018","unstructured":"Maeng Y, Kim KT, Zhou X, Jin L, Kim KS, Kim YH, et al. A novel microbial technique for producing high-quality sophorolipids from horse oil suitable for cosmetic applications. Microb Biotechnol. 2018;11(5):917\u201329. https:\/\/doi.org\/10.1111\/1751-7915.13297.","journal-title":"Microb Biotechnol"},{"issue":"11","key":"4202_CR55","doi-asserted-by":"publisher","first-page":"4565","DOI":"10.1007\/s00253-019-09808-w","volume":"103","author":"J Liu","year":"2019","unstructured":"Liu J, Li W, Zhu X, Zhao H, Lu Y, Zhang C, et al. Surfactin effectively inhibits Staphylococcus aureus adhesion and biofilm formation on surfaces. Appl Microbiol Biotechnol. 2019;103(11):4565\u201374. https:\/\/doi.org\/10.1007\/s00253-019-09808-w.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"9","key":"4202_CR56","doi-asserted-by":"publisher","first-page":"5305","DOI":"10.1128\/IAI.69.9.5305-5312.2001","volume":"69","author":"VMF Lima","year":"2001","unstructured":"Lima VMF, Bonato VLD, Lima KM, Dos Santos SA, Dos Santos RR, Gon\u00e7alves EDC, et al. Role of trehalose dimycolate in recruitment of cells and modulation of production of cytokines and NO in tuberculosis. Infect Immun. 2001;69(9):5305\u201312. https:\/\/doi.org\/10.1128\/IAI.69.9.5305-5312.2001.","journal-title":"Infect Immun"},{"key":"4202_CR57","doi-asserted-by":"publisher","unstructured":"Rodrigues AI, Gudi\u00f1a EJ, Teixeira JA, Rodrigues LR. Sodium chloride effect on the aggregation behaviour of rhamnolipids and their antifungal activity. Sci Rep. 2017;7(1). https:\/\/doi.org\/10.1038\/s41598-017-13424-x","DOI":"10.1038\/s41598-017-13424-x"},{"issue":"7\u20138","key":"4202_CR58","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1016\/j.bbamem.2008.05.003","volume":"1778","author":"J P\u00e9rez-Gil","year":"2008","unstructured":"P\u00e9rez-Gil J. Structure of pulmonary surfactant membranes and films: The role of proteins and lipid-protein interactions. Biochim Biophys Acta Biomembr. 2008;1778(7\u20138):1676\u201395. https:\/\/doi.org\/10.1016\/j.bbamem.2008.05.003.","journal-title":"Biochim Biophys Acta Biomembr"},{"issue":"12","key":"4202_CR59","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.tips.2013.10.002","volume":"34","author":"EJ Gudi\u00f1a","year":"2013","unstructured":"Gudi\u00f1a EJ, Rangarajan V, Sen R, Rodrigues LR. Potential therapeutic applications of biosurfactants. Trends Pharmacol Sci. 2013;34(12):667\u201375. https:\/\/doi.org\/10.1016\/j.tips.2013.10.002.","journal-title":"Trends Pharmacol Sci"},{"issue":"7","key":"4202_CR60","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1080\/07388551.2016.1269053","volume":"37","author":"X Vecino","year":"2017","unstructured":"Vecino X, Cruz JM, Moldes AB, Rodrigues LR. Biosurfactants in cosmetic formulations: trends and challenges. Crit Rev Biotechnol. 2017;37(7):911\u201323. https:\/\/doi.org\/10.1080\/07388551.2016.1269053.","journal-title":"Crit Rev Biotechnol"},{"key":"4202_CR61","doi-asserted-by":"publisher","unstructured":"Sen R, Mudhoo A, Gunaseelan D. Biosurfactants: Synthesis, Properties and Applications in Environmental Bioremediation. Bioremediation and Sustainability: Research and Applications. 2012;137\u2013211. https:\/\/doi.org\/10.1002\/9781118371220.ch4.","DOI":"10.1002\/9781118371220.ch4"},{"issue":"1","key":"4202_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep39303","volume":"6","author":"P Gan","year":"2016","unstructured":"Gan P, Gao Z, Zhao X, Qi G. Surfactin inducing mitochondria-dependent ROS to activate MAPKs, NF-\u03ba B and inflammasomes in macrophages for adjuvant activity. Sci Rep. 2016;6(1):1\u201311. https:\/\/doi.org\/10.1038\/srep39303.","journal-title":"Sci Rep"},{"key":"4202_CR63","doi-asserted-by":"publisher","unstructured":"Xu R, Ma L, Chen T, Wang J. Sophorolipid Suppresses LPS-Induced Inflammation in RAW264.7 Cells through the NF-\u03baB Signaling Pathway. Molecules. 2022;27(15). https:\/\/doi.org\/10.3390\/molecules27155037.","DOI":"10.3390\/molecules27155037"},{"issue":"2","key":"4202_CR64","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00253-010-2589-0","volume":"87","author":"IM Banat","year":"2010","unstructured":"Banat IM, Franzetti A, Gandolfi I, Bestetti G, Martinotti MG, Fracchia L, et al. Microbial biosurfactants production, applications and future potential. Appl Microbiol Biotechnol. 2010;87(2):427\u201344. https:\/\/doi.org\/10.1007\/s00253-010-2589-0.","journal-title":"Appl Microbiol Biotechnol"},{"key":"4202_CR65","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/B978-0-323-85146-6.00022-X","volume-title":"Green sustainable process for chemical and environmental engineering and science: biomedical application of biosurfactant in medical sector","author":"S Bahadur","year":"2022","unstructured":"Bahadur S, Pathak K, Pattnaik S, Swain K. Biosurfactants for optimal delivery of poorly soluble therapeutic agents. In: Green sustainable process for chemical and environmental engineering and science: biomedical application of biosurfactant in medical sector. INC; 2022. p. 543\u201358. https:\/\/doi.org\/10.1016\/B978-0-323-85146-6.00022-X."},{"key":"4202_CR66","doi-asserted-by":"publisher","unstructured":"Whitsett JA, Wert SE, Weaver TE. Alveolar surfactant homeostasis and the pathogenesis of pulmonary disease. Annual Review of Medicine. 2010. p. 105\u201319. https:\/\/doi.org\/10.1146\/annurev.med.60.041807.123500.","DOI":"10.1146\/annurev.med.60.041807.123500"},{"issue":"1","key":"4202_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12944-020-01278-8","volume":"19","author":"CW Agudelo","year":"2020","unstructured":"Agudelo CW, Samaha G, Garcia-Arcos I. Alveolar lipids in pulmonary disease. A review Lipids Health Dis. 2020;19(1):1\u201321. https:\/\/doi.org\/10.1186\/s12944-020-01278-8.","journal-title":"A review Lipids Health Dis"},{"issue":"2","key":"4202_CR68","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1164\/rccm.200711-1661OC","volume":"178","author":"WJ Janssen","year":"2008","unstructured":"Janssen WJ, McPhillips KA, Dickinson MG, Linderman DJ, Morimoto K, Xiao YQ, et al. Surfactant proteins A and D suppress alveolar macrophage phagocytosis via interaction with SIRP\u03b1. Am J Respir Crit Care Med. 2008;178(2):158\u201367. https:\/\/doi.org\/10.1164\/rccm.200711-1661OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"4202_CR69","doi-asserted-by":"publisher","unstructured":"Milad N, Morissette MC. Revisiting the role of pulmonary surfactant in chronic inflammatory lung diseases and environmental exposure. European Respiratory Review. 2021;30(162). https:\/\/doi.org\/10.1183\/16000617.0077-2021.","DOI":"10.1183\/16000617.0077-2021"},{"issue":"September","key":"4202_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2021.730022","volume":"12","author":"J Ji","year":"2021","unstructured":"Ji J, Sun L, Luo Z, Zhang Y, Xianzheng W, Liao Y, et al. Potential Therapeutic Applications of Pulmonary Surfactant Lipids in the Host Defence Against Respiratory Viral Infections. Front Immunol. 2021;12(September):1\u20138. https:\/\/doi.org\/10.3389\/fimmu.2021.730022.","journal-title":"Front Immunol"},{"issue":"1","key":"4202_CR71","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s10989-024-10586-x","volume":"30","author":"MA Bejeshk","year":"2024","unstructured":"Bejeshk MA, Rajizadeh MA, Yari A, Bagheri F, Najafipour H, Dehghannoudeh G, et al. Lipopeptide Biosurfactant Produced by Acinetobacter junii B6 Attenuates Lung Inflammatory, Oxidative, and Histopathological Alterations due to Asthma in Rats. Int J Pept Res Ther. 2024;30(1):3\u20135. https:\/\/doi.org\/10.1007\/s10989-024-10586-x.","journal-title":"Int J Pept Res Ther"},{"issue":"1","key":"4202_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3349\/YMJ.2022.63.1.1","volume":"63","author":"JW Park","year":"2022","unstructured":"Park JW. Asthma phenotype with metabolic dysfunction. Yonsei Med J. 2022;63(1):1\u20137. https:\/\/doi.org\/10.3349\/YMJ.2022.63.1.1.","journal-title":"Yonsei Med J"},{"issue":"5","key":"4202_CR73","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1513\/AnnalsATS.201411-507FR","volume":"12","author":"SH Han","year":"2015","unstructured":"Han SH, Mallampalli RK. The role of surfactant in lung disease and host defense against pulmonary infections. Ann Am Thorac Soc. 2015;12(5):765\u201374. https:\/\/doi.org\/10.1513\/AnnalsATS.201411-507FR.","journal-title":"Ann Am Thorac Soc"},{"issue":"1","key":"4202_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3349\/YMJ.2022.63.1.1","volume":"63","author":"JW Park","year":"2022","unstructured":"Park JW. Asthma phenotype with metabolic dysfunction. Yonsei Med J. 2022;63(1):1\u20137. https:\/\/doi.org\/10.3349\/YMJ.2022.63.1.1.","journal-title":"Yonsei Med J"},{"issue":"5","key":"4202_CR75","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1513\/AnnalsATS.201411-507FR","volume":"12","author":"SH Han","year":"2015","unstructured":"Han SH, Mallampalli RK. The role of surfactant in lung disease and host defense against pulmonary infections. Ann Am Thorac Soc. 2015;12(5):765\u201374. https:\/\/doi.org\/10.1513\/AnnalsATS.201411-507FR.","journal-title":"Ann Am Thorac Soc"},{"issue":"6","key":"4202_CR76","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1007\/s10753-014-9942-x","volume":"37","author":"J Wang","year":"2014","unstructured":"Wang J, Liu YT, Xiao L, Zhu L, Wang Q, Yan T. Anti-Inflammatory Effects of Apigenin in Lipopolysaccharide-Induced Inflammatory in Acute Lung Injury by Suppressing COX-2 and NF-kB Pathway. Inflammation. 2014;37(6):2085\u201390. https:\/\/doi.org\/10.1007\/s10753-014-9942-x.","journal-title":"Inflammation"},{"issue":"10","key":"4202_CR77","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1016\/j.bbamem.2008.03.021","volume":"1778","author":"YY Zuo","year":"2008","unstructured":"Zuo YY, Veldhuizen RAW, Neumann AW, Petersen NO, Possmayer F. Current perspectives in pulmonary surfactant - Inhibition, enhancement and evaluation. Biochim Biophys Acta Biomembr. 2008;1778(10):1947\u201377. https:\/\/doi.org\/10.1016\/j.bbamem.2008.03.021.","journal-title":"Biochim Biophys Acta Biomembr"},{"issue":"7\u20138","key":"4202_CR78","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.intimp.2009.03.013","volume":"9","author":"SY Park","year":"2009","unstructured":"Park SY, Kim YH. Surfactin inhibits immunostimulatory function of macrophages through blocking NK-\u03baB MAPK and Akt pathway. Int Immunopharmacol. 2009;9(7\u20138):886\u201393. https:\/\/doi.org\/10.1016\/j.intimp.2009.03.013.","journal-title":"Int Immunopharmacol"},{"key":"4202_CR79","doi-asserted-by":"publisher","unstructured":"Wahab ZHA, Al-Sahlany STG. Bacterial Biosurfactants as Bioactive Ingredients: Surfactin\u2019s Role in Food Preservation, Functional Foods, and Human Health. Bacteria. 2025;4(4). https:\/\/doi.org\/10.3390\/bacteria4040049.","DOI":"10.3390\/bacteria4040049"},{"issue":"1","key":"4202_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41522-018-0066-1","volume":"4","author":"TL Wood","year":"2018","unstructured":"Wood TL, Gong T, Zhu L, Miller J, Miller DS, Yin B, et al. Rhamnolipids from Pseudomonas aeruginosa disperse the biofilms of sulfate-reducing bacteria. NPJ Biofilms Microbiomes. 2018;4(1):1\u20138. https:\/\/doi.org\/10.1038\/s41522-018-0066-1.","journal-title":"NPJ Biofilms Microbiomes"},{"issue":"5986","key":"4202_CR81","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1126\/science.1188302","volume":"328","author":"D Huh","year":"2010","unstructured":"Huh D, Matthews BD, Mammoto A, Montoya-Zavala M, Yuan Hsin H, Ingber DE. Reconstituting organ-level lung functions on a chip. Science (1979). 2010;328(5986):1662\u20138. https:\/\/doi.org\/10.1126\/science.1188302.","journal-title":"Science (1979)"},{"issue":"2","key":"4202_CR82","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/nmeth.3697","volume":"13","author":"KH Benam","year":"2016","unstructured":"Benam KH, Villenave R, Lucchesi C, Varone A, Hubeau C, Lee HH, et al. Small airway-on-a-chip enables analysis of human lung inflammation and drug responses in vitro. Nat Methods. 2016;13(2):151\u20137. https:\/\/doi.org\/10.1038\/nmeth.3697.","journal-title":"Nat Methods"},{"issue":"1","key":"4202_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-023-36863-1","volume":"13","author":"T Leach","year":"2023","unstructured":"Leach T, Gandhi U, Reeves KD, Stumpf K, Okuda K, Marini FC, et al. Development of a novel air\u2013liquid interface airway tissue equivalent model for in vitro respiratory modeling studies. Sci Rep. 2023;13(1):1\u201315. https:\/\/doi.org\/10.1038\/s41598-023-36863-1.","journal-title":"Sci Rep"},{"key":"4202_CR84","doi-asserted-by":"publisher","unstructured":"Hickey AJ. Inhalation aerosols: physical and biological basis for therapy. 2nd ed. Boca Raton: CRC Press; 2006. 473 p. https:\/\/doi.org\/10.3109\/9781420019537.","DOI":"10.3109\/9781420019537"},{"key":"4202_CR85","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.fitote.2014.04.016","volume":"96","author":"E Zhou","year":"2014","unstructured":"Zhou E, Fu Y, Wei Z, Yu Y, Zhang X, Yang Z. Thymol attenuates allergic airway inflammation in ovalbumin (OVA)-induced mouse asthma. Fitoterapia. 2014;96:131\u20137. https:\/\/doi.org\/10.1016\/j.fitote.2014.04.016.","journal-title":"Fitoterapia"},{"issue":"12","key":"4202_CR86","first-page":"1984","volume":"18","author":"SE Byeon","year":"2008","unstructured":"Byeon SE, Yong GL, Byung HK, Ting S, Sang YL, Hwa JP, et al. Surfactin Blocks NO Production in Lipopolysaccharide-activated Macrophages by Inhibiting NF-kB Activation. J Microbiol Biotechnol. 2008;18(12):1984\u20139.","journal-title":"J Microbiol Biotechnol"},{"issue":"5","key":"4202_CR87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BSR20160204","volume":"36","author":"W Xu","year":"2016","unstructured":"Xu W, Liu H, Wang X, Yang Q. Surfactin induces maturation of dendritic cells in vitro. Biosci Rep. 2016;36(5):1\u20137. https:\/\/doi.org\/10.1042\/BSR20160204.","journal-title":"Biosci Rep."},{"issue":"7\u20138","key":"4202_CR88","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.intimp.2009.03.013","volume":"9","author":"SY Park","year":"2009","unstructured":"Park SY, Kim YH. Surfactin inhibits immunostimulatory function of macrophages through blocking NK-\u03baB MAPK and Akt pathway. Int Immunopharmacol. 2009;9(7\u20138):886\u201393. https:\/\/doi.org\/10.1016\/j.intimp.2009.03.013.","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"4202_CR89","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","volume":"140","author":"K Schroder","year":"2010","unstructured":"Schroder K, Tschopp J. The Inflammasomes. Cell. 2010;140(6):821\u201332. https:\/\/doi.org\/10.1016\/j.cell.2010.01.040.","journal-title":"Cell"},{"issue":"7","key":"4202_CR90","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nri.2016.58","volume":"16","author":"P Broz","year":"2016","unstructured":"Broz P, Dixit VM. Inflammasomes: Mechanism of assembly, regulation and signalling. Nat Rev Immunol. 2016;16(7):407\u201320. https:\/\/doi.org\/10.1038\/nri.2016.58.","journal-title":"Nat Rev Immunol"},{"key":"4202_CR91","doi-asserted-by":"publisher","unstructured":"Mousa AM, Nooman MU, Abbas SS, Gebril SM, Abdelraof M, Al-kashef AS. Protective effects of microbial biosurfactants produced by Bacillus halotolerans and Candida parapsilosis on bleomycin-induced pulmonary fibrosis in mice: Impact of antioxidant, anti-inflammatory and anti-fibrotic properties via TGF-\u03b21\/Smad-3 pathway and . Toxicol Appl Pharmacol. 2024;486(April):116939. https:\/\/doi.org\/10.1016\/j.taap.2024.116939.","DOI":"10.1016\/j.taap.2024.116939"},{"issue":"1","key":"4202_CR92","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s42770-023-01228-3","volume":"55","author":"D Saiyam","year":"2024","unstructured":"Saiyam D, Dubey A, Malla MA, Kumar A. Lipopeptides from Bacillus: unveiling biotechnological prospects\u2014sources, properties, and diverse applications. Braz J Microbiol. 2024;55(1):281\u201395. https:\/\/doi.org\/10.1007\/s42770-023-01228-3.","journal-title":"Braz J Microbiol"},{"issue":"2","key":"4202_CR93","doi-asserted-by":"publisher","first-page":"303","DOI":"10.18502\/ijm.v17i2.18397","volume":"17","author":"MA Taghavi","year":"2025","unstructured":"Taghavi MA, Ahmadi M, Dehghan-Nayeri D, Salehi Z, Shams-Ghahfarokhi M, Jamzivar F, et al. Antifungal effect of soil Bacillus bacteria on pathogenic species of the fungal genera Aspergillus and Trichophyton. Iran J Microbiol. 2025;17(2):303\u201311. https:\/\/doi.org\/10.18502\/ijm.v17i2.18397.","journal-title":"Iran J Microbiol"},{"issue":"5","key":"4202_CR94","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/BF02931577","volume":"51","author":"V B\u011bhal","year":"2006","unstructured":"B\u011bhal V. Mode of action of microbial bioactive metabolites. Folia Microbiol (Praha). 2006;51(5):359\u201369. https:\/\/doi.org\/10.1007\/BF02931577.","journal-title":"Folia Microbiol (Praha)"},{"issue":"3","key":"4202_CR95","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.tibtech.2004.01.010","volume":"22","author":"P Singh","year":"2004","unstructured":"Singh P, Cameotra SS. Potential applications of microbial surfactants in biomedical sciences. Trends Biotechnol. 2004;22(3):142\u20136. https:\/\/doi.org\/10.1016\/j.tibtech.2004.01.010.","journal-title":"Trends Biotechnol"},{"issue":"6","key":"4202_CR96","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1111\/j.1365-2672.2007.03701.x","volume":"104","author":"P Das","year":"2008","unstructured":"Das P, Mukherjee S, Sen R. Antimicrobial potential of a lipopeptide biosurfactant derived from a marine Bacillus circulans. J Appl Microbiol. 2008;104(6):1675\u201384. https:\/\/doi.org\/10.1111\/j.1365-2672.2007.03701.x.","journal-title":"J Appl Microbiol"},{"issue":"7","key":"4202_CR97","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1007\/s12010-009-8707-8","volume":"160","author":"M Nitschke","year":"2010","unstructured":"Nitschke M, Costa SGVAO, Contiero J. Structure and applications of a rhamnolipid surfactant produced in soybean oil waste. Appl Biochem Biotechnol. 2010;160(7):2066\u201374. https:\/\/doi.org\/10.1007\/s12010-009-8707-8.","journal-title":"Appl Biochem Biotechnol"},{"issue":"2","key":"4202_CR98","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1007\/s00253-006-0674-1","volume":"74","author":"X Huang","year":"2007","unstructured":"Huang X, Lu Z, Bie X, L\u00fc FX, Zhao H, Yang S. Optimization of inactivation of endospores of Bacillus cereus by antimicrobial lipopeptides from Bacillus subtilis fmbj strains using a response surface method. Appl Microbiol Biotechnol. 2007;74(2):454\u201361. https:\/\/doi.org\/10.1007\/s00253-006-0674-1.","journal-title":"Appl Microbiol Biotechnol"},{"key":"4202_CR99","doi-asserted-by":"publisher","unstructured":"Horng YB, Yu YH, Dybus A, Hsiao FSH, Cheng YH. Antibacterial activity of Bacillus species-derived surfactin on Brachyspira hyodysenteriae and Clostridium perfringens. AMB Express. 2019;9(1). https:\/\/doi.org\/10.1186\/s13568-019-0914-2.","DOI":"10.1186\/s13568-019-0914-2"},{"key":"4202_CR100","doi-asserted-by":"publisher","unstructured":"Davey ME, Caiazza NC, Toole G a O. Rhamnolipid Surfactant Production Affects Bio lm Architecture in. Microbiology (N Y). 2003;185(3):1027\u201336. https:\/\/doi.org\/10.1128\/JB.185.3.1027.","DOI":"10.1128\/JB.185.3.1027"},{"issue":"11","key":"4202_CR101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00284-024-03892-6","volume":"81","author":"S Dhadwal","year":"2024","unstructured":"Dhadwal S, Handa S, Chatterjee M, Banat IM. Sophorolipid: An Effective Biomolecule for Targeting Microbial Biofilms. Curr Microbiol. 2024;81(11):1\u201316. https:\/\/doi.org\/10.1007\/s00284-024-03892-6.","journal-title":"Curr Microbiol"},{"issue":"21","key":"4202_CR102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/jvi.00809-18","volume":"92","author":"L Yuan","year":"2018","unstructured":"Yuan L, Zhang S, Wang Y, Li Y, Wang X, Yang Q. Surfactin Inhibits Membrane Fusion during Invasion of Epithelial Cells by Enveloped Viruses. J Virol. 2018;92(21):1\u201319. https:\/\/doi.org\/10.1128\/jvi.00809-18.","journal-title":"J Virol"},{"issue":"3","key":"4202_CR103","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1006\/biol.1997.0099","volume":"25","author":"D Vollenbroich","year":"1997","unstructured":"Vollenbroich D, \u00d6zel M, Vater J, Kamp RM, Pauli G. Mechanism of inactivation of enveloped viruses by the biosurfactant surfactin from Bacillus subtilis. Biologicals. 1997;25(3):289\u201397. https:\/\/doi.org\/10.1006\/biol.1997.0099.","journal-title":"Biologicals"},{"key":"4202_CR104","doi-asserted-by":"publisher","unstructured":"Hoste ACR, Smeralda W, Cugnet A, Brostaux Y, Deleu M, Garigliany M, Jacques P. The structure of lipopeptides impacts their antiviral activity and mode of action against SARS-CoV-2 in vitro. Appl Environ Microbiol. 2024;90(11):e0103624. https:\/\/doi.org\/10.1128\/aem.01036-24.","DOI":"10.1128\/aem.01036-24"},{"issue":"3","key":"4202_CR105","doi-asserted-by":"publisher","first-page":"680","DOI":"10.3390\/applmicrobiol2030052","volume":"2","author":"S Crovella","year":"2022","unstructured":"Crovella S, de Freitas LC, Zupin L, Fontana F, Ruscio M, Pena EPN, et al. Surfactin bacterial antiviral lipopeptide blocks in vitro replication of SARS-CoV-2. Appl Microbiol. 2022;2(3):680\u20137. https:\/\/doi.org\/10.3390\/applmicrobiol2030052.","journal-title":"Appl Microbiol"},{"issue":"4","key":"4202_CR106","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s10989-006-9041-4","volume":"12","author":"X Huang","year":"2006","unstructured":"Huang X, Lu Z, Zhao H, Bie X, L\u00fc FX, Yang S. Antiviral activity of antimicrobial lipopeptide from Bacillus subtilis fmbj against Pseudorabies Virus, Porcine Parvovirus, Newcastle Disease Virus and Infectious Bursal Disease Virus in vitro. Int J Pept Res Ther. 2006;12(4):373\u20137. https:\/\/doi.org\/10.1007\/s10989-006-9041-4.","journal-title":"Int J Pept Res Ther"},{"issue":"10","key":"4202_CR107","doi-asserted-by":"publisher","first-page":"4093","DOI":"10.1128\/AAC.49.10.4093-4100.2005","volume":"49","author":"V Shah","year":"2005","unstructured":"Shah V, Doncel GF, Seyoum T, Eaton KM, Zalenskaya I, Hagver R, et al. Sophorolipids, microbial glycolipids with anti-human immunodeficiency virus and sperm-immobilizing activities. Antimicrob Agents Chemother. 2005;49(10):4093\u2013100. https:\/\/doi.org\/10.1128\/AAC.49.10.4093-4100.2005.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1\u20132","key":"4202_CR108","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1515\/znc-2008-1-214","volume":"63","author":"M Remichkova","year":"2008","unstructured":"Remichkova M, Galabova D, Roeva I, Karpenko E, Shulga A, Galabov AS. Anti-herpesvirus activities of Pseudomonas sp. S-17 rhamnolipid and its complex with alginate. Z Naturforsch C J Biosci. 2008;63(1\u20132):75\u201381. https:\/\/doi.org\/10.1515\/znc-2008-1-214.","journal-title":"Z Naturforsch C J Biosci"},{"issue":"1","key":"4202_CR109","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13568-014-0040-0","volume":"4","author":"C Duarte","year":"2014","unstructured":"Duarte C, Gudi\u00f1a EJ, Lima CF, Rodrigues LR. Effects of biosurfactants on the viability and proliferation of human breast cancer cells. AMB Express. 2014;4(1):1\u201312. https:\/\/doi.org\/10.1186\/s13568-014-0040-0.","journal-title":"AMB Express"},{"issue":"3","key":"4202_CR110","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s12013-009-9065-4","volume":"55","author":"X Cao","year":"2009","unstructured":"Cao X, Wang AH, Jiao RZ, Wang CL, Mao DZ, Yan L, et al. Surfactin induces apoptosis and G2\/M arrest in human breast cancer MCF-7 cells through cell cycle factor regulation. Cell Biochem Biophys. 2009;55(3):163\u201371. https:\/\/doi.org\/10.1007\/s12013-009-9065-4.","journal-title":"Cell Biochem Biophys"},{"issue":"1","key":"4202_CR111","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3892\/ijo.2012.1695","volume":"42","author":"SY Park","year":"2013","unstructured":"Park SY, Kim JH, Lee YJ, Lee SJ, Kim Y. Surfactin suppresses TPA-induced breast cancer cell invasion through the inhibition of MMP-9 expression. Int J Oncol. 2013;42(1):287\u201396. https:\/\/doi.org\/10.3892\/ijo.2012.1695.","journal-title":"Int J Oncol"},{"issue":"3","key":"4202_CR112","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.cbi.2009.11.027","volume":"183","author":"X Cao","year":"2010","unstructured":"Cao X, Wang A, Wang C, Mao D, Lu M, Cui Y, et al. Surfactin induces apoptosis in human breast cancer MCF-7 cells through a ROS\/JNK-mediated mitochondrial\/caspase pathway. Chem Biol Interact. 2010;183(3):357\u201362. https:\/\/doi.org\/10.1016\/j.cbi.2009.11.027.","journal-title":"Chem Biol Interact"},{"issue":"4","key":"4202_CR113","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s10532-018-09865-4","volume":"30","author":"F Abdelli","year":"2019","unstructured":"Abdelli F, Jardak M, Elloumi J, Stien D, Cherif S, Mnif S, et al. Antibacterial, anti-adherent and cytotoxic activities of surfactin(s) from a lipolytic strain Bacillus safensis F4. Biodegradation. 2019;30(4):287\u2013300. https:\/\/doi.org\/10.1007\/s10532-018-09865-4.","journal-title":"Biodegradation"},{"issue":"5","key":"4202_CR114","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1007\/s00253-020-11045-5","volume":"105","author":"X Wang","year":"2021","unstructured":"Wang X, Xu N, Li Q, Chen S, Cheng H, Yang M, et al. Lactonic sophorolipid\u2013induced apoptosis in human HepG2 cells through the Caspase-3 pathway. Appl Microbiol Biotechnol. 2021;105(5):2033\u201342. https:\/\/doi.org\/10.1007\/s00253-020-11045-5.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"1","key":"4202_CR115","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s00253-005-0243-z","volume":"72","author":"J Chen","year":"2006","unstructured":"Chen J, Song X, Zhang H, Qu YB, Miao JY. Sophorolipid produced from the new yeast strain Wickerhamiella domercqiae induces apoptosis in H7402 human liver cancer cells. Appl Microbiol Biotechnol. 2006;72(1):52\u20139. https:\/\/doi.org\/10.1007\/s00253-005-0243-z.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"3","key":"4202_CR116","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/jmr.2403","volume":"28","author":"IAC Ribeiro","year":"2015","unstructured":"Ribeiro IAC, Faustino CMC, Guerreiro PS, Frade RFM, Bronze MR, Castro MF, et al. Development of novel sophorolipids with improved cytotoxic activity toward MDA-MB-231 breast cancer cells. J Mol Recognit. 2015;28(3):155\u201365. https:\/\/doi.org\/10.1002\/jmr.2403.","journal-title":"J Mol Recognit"},{"issue":"5","key":"4202_CR117","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1021\/acs.jnatprod.2c00804","volume":"86","author":"CL Roberge","year":"2023","unstructured":"Roberge CL, Miceli RT, Murphy LR, Kingsley DM, Gross RA, Corr DT. Sophorolipid Candidates Demonstrate Cytotoxic Efficacy against 2D and 3D Breast Cancer Models. J Nat Prod. 2023;86(5):1159\u201370. https:\/\/doi.org\/10.1021\/acs.jnatprod.2c00804.","journal-title":"J Nat Prod"},{"issue":"7","key":"4202_CR118","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/separations8070092","volume":"8","author":"S Semkova","year":"2021","unstructured":"Semkova S, Antov G, Iliev I, Tsoneva I, Lefterov P, Christova N, et al. Rhamnolipid biosurfactants\u2014Possible natural anticancer agents and autophagy inhibitors. Separations. 2021;8(7):1\u201314. https:\/\/doi.org\/10.3390\/separations8070092.","journal-title":"Separations"},{"issue":"June","key":"4202_CR119","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.colsurfb.2019.06.058","volume":"181","author":"K Rahimi","year":"2019","unstructured":"Rahimi K, Lotfabad TB, Jabeen F, Mohammad Ganji S. Cytotoxic effects of mono- and di-rhamnolipids from Pseudomonas aeruginosa MR01 on MCF-7 human breast cancer cells. Colloids Surf B Biointerfaces. 2019;181(June):943\u201352. https:\/\/doi.org\/10.1016\/j.colsurfb.2019.06.058.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"November","key":"4202_CR120","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fbioe.2021.761266","volume":"9","author":"N Mishra","year":"2021","unstructured":"Mishra N, Rana K, Seelam SD, Kumar R, Pandey V, Salimath BP, et al. Characterization and Cytotoxicity of Pseudomonas Mediated Rhamnolipids Against Breast Cancer MDA-MB-231 Cell Line. Front Bioeng Biotechnol. 2021;9(November):1\u201314. https:\/\/doi.org\/10.3389\/fbioe.2021.761266.","journal-title":"Front Bioeng Biotechnol"},{"key":"4202_CR121","doi-asserted-by":"publisher","unstructured":"Twigg MS, Adu SA, Sugiyama S, Marchant R, Banat IM. Mono-Rhamnolipid Biosurfactants Synthesized by Pseudomonas aeruginosa Detrimentally Affect Colorectal Cancer Cells. Pharmaceutics. 2022;14(12). https:\/\/doi.org\/10.3390\/pharmaceutics14122799.","DOI":"10.3390\/pharmaceutics14122799"},{"issue":"4","key":"4202_CR122","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s11095-013-1210-5","volume":"31","author":"CJ Wallace","year":"2014","unstructured":"Wallace CJ, Medina SH, ElSayed MEH. Effect of rhamnolipids on permeability across Caco-2 cell monolayers. Pharm Res. 2014;31(4):887\u201394. https:\/\/doi.org\/10.1007\/s11095-013-1210-5.","journal-title":"Pharm Res"},{"issue":"11","key":"4202_CR123","doi-asserted-by":"publisher","first-page":"3855","DOI":"10.1007\/s12010-021-03620-x","volume":"193","author":"PE Feuser","year":"2021","unstructured":"Feuser PE, Coelho ALS, de Melo ME, Scussel R, Carciofi BAM, Machado-de-\u00c1vila RA, et al. Apoptosis Induction in Murine Melanoma (B16F10) Cells by Mannosylerythritol Lipids-B; a Glycolipid Biosurfactant with Antitumoral Activities. Appl Biochem Biotechnol. 2021;193(11):3855\u201366. https:\/\/doi.org\/10.1007\/s12010-021-03620-x.","journal-title":"Appl Biochem Biotechnol"},{"issue":"2","key":"4202_CR124","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0148198","volume":"11","author":"L Fan","year":"2016","unstructured":"Fan L, Li H, Niu Y, Chen Q. Characterization and inducing melanoma cell apoptosis activity of mannosylerythritol lipids-A produced from pseudozyma aphidis. PLoS ONE. 2016;11(2):1\u201317. https:\/\/doi.org\/10.1371\/journal.pone.0148198.","journal-title":"PLoS ONE"},{"key":"4202_CR125","doi-asserted-by":"publisher","unstructured":"Meng J, Yasui C, Shida M, Toshima K, Takahashi D. Designed Mannosylerythritol Lipid Analogues Exhibiting Both Selective Cytotoxicity Against Human Skin Cancer Cells and Recovery Effects on Damaged Skin Cells. Chemistry - A European Journal. 2024;30(48):1\u20137. https:\/\/doi.org\/10.1002\/chem.202401319","DOI":"10.1002\/chem.202401319"},{"issue":"1","key":"4202_CR126","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00253-022-12302-5","volume":"107","author":"SA Adu","year":"2023","unstructured":"Adu SA, Twigg MS, Naughton PJ, Marchant R, Banat IM. Characterisation of cytotoxicity and immunomodulatory effects of glycolipid biosurfactants on human keratinocytes. Appl Microbiol Biotechnol. 2023;107(1):137\u201352. https:\/\/doi.org\/10.1007\/s00253-022-12302-5.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"24","key":"4202_CR127","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ani12243456","volume":"12","author":"WC Tsai","year":"2022","unstructured":"Tsai WC, Wong WT, Hsu HT, Cheng YH, Yu YH, Chen WJ, et al. Surfactin containing Bacillus licheniformis-fermented products alleviate dextran sulfate sodium-induced colitis by inhibiting colonic inflammation and the NLRP3 inflammasome in mice. Animals (Basel). 2022;12(24):1\u201312. https:\/\/doi.org\/10.3390\/ani12243456.","journal-title":"Animals (Basel)"},{"key":"4202_CR128","doi-asserted-by":"publisher","unstructured":"Jia J, Fu M, Ji W, Xiong N, Chen P, Lin J, et al. Surfactin from Bacillus subtilis enhances immune response and contributes to the maintenance of intestinal microbial homeostasis . Microbiol Spectr. 2024;12(12). https:\/\/doi.org\/10.1128\/spectrum.00918-24.","DOI":"10.1128\/spectrum.00918-24"},{"key":"4202_CR129","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.nano.2019.03.015","volume":"19","author":"G Yi","year":"2019","unstructured":"Yi G, Son J, Yoo J, Park C, Koo H. Rhamnolipid nanoparticles for in vivo drug delivery and photodynamic therapy. Nanomedicine (Lond). 2019;19:12\u201321. https:\/\/doi.org\/10.1016\/j.nano.2019.03.015.","journal-title":"Nanomedicine (Lond)"},{"issue":"2","key":"4202_CR130","doi-asserted-by":"publisher","first-page":"1","DOI":"10.47611\/jsrhs.v10i2.1495","volume":"10","author":"E Shusterman","year":"2021","unstructured":"Shusterman E, Mottahedeh A, McCarthy M. The synergistic effects of rhamnolipids and antibiotics against bacteria. J Stud Res. 2021;10(2):1\u20137. https:\/\/doi.org\/10.47611\/jsrhs.v10i2.1495.","journal-title":"J Stud Res"},{"key":"4202_CR131","doi-asserted-by":"publisher","unstructured":"Wahab ZHA, Al-Sahlany STG. Bacterial Biosurfactants as Bioactive Ingredients: Surfactin\u2019s Role in Food Preservation, Functional Foods, and Human Health. Bacteria. 2025;4(4):49. https:\/\/doi.org\/10.3390\/bacteria4040049.","DOI":"10.3390\/bacteria4040049"},{"issue":"25","key":"4202_CR132","doi-asserted-by":"publisher","first-page":"16105","DOI":"10.1039\/d1ra08796g","volume":"12","author":"B Alvarez Chavez","year":"2022","unstructured":"Alvarez Chavez B, Raghavan V, Tartakovsky B. A comparative analysis of biopolymer production by microbial and bioelectrochemical technologies. RSC Adv. 2022;12(25):16105\u201318. https:\/\/doi.org\/10.1039\/d1ra08796g.","journal-title":"RSC Adv"},{"issue":"4","key":"4202_CR133","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.jbiotec.2012.05.022","volume":"162","author":"MM M\u00fcller","year":"2012","unstructured":"M\u00fcller MM, K\u00fcgler JH, Henkel M, Gerlitzki M, H\u00f6rmann B, P\u00f6hnlein M, et al. Rhamnolipids-next generation surfactants? J Biotechnol. 2012;162(4):366\u201380. https:\/\/doi.org\/10.1016\/j.jbiotec.2012.05.022.","journal-title":"J Biotechnol"},{"issue":"7","key":"4202_CR134","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/biot.201600561","volume":"12","author":"M Henkel","year":"2017","unstructured":"Henkel M, Geissler M, Weggenmann F, Hausmann R. Production of microbial biosurfactants: status quo of rhamnolipid and surfactin towards large-scale production. Biotechnol J. 2017;12(7):1\u201310. https:\/\/doi.org\/10.1002\/biot.201600561.","journal-title":"Biotechnol J"},{"key":"4202_CR135","doi-asserted-by":"publisher","DOI":"10.1186\/s12934-017-0753-2","author":"H Chong","year":"2017","unstructured":"Chong H, Li Q. Microbial production of rhamnolipids: opportunities, challenges and strategies. Microb Cell Fact. 2017. https:\/\/doi.org\/10.1186\/s12934-017-0753-2.","journal-title":"Microb Cell Fact"},{"issue":"2","key":"4202_CR136","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10532-025-10121-9","volume":"36","author":"N Sharma","year":"2025","unstructured":"Sharma N, Ahlawat YK, Sharma AJ, Chamoli N, Thakur M, Sharma A, et al. A comprehensive review on microbial production and significant applications of multifunctional biomolecules: biosurfactants. Biodegradation. 2025;36(2):1\u201323. https:\/\/doi.org\/10.1007\/s10532-025-10121-9.","journal-title":"Biodegradation"},{"key":"4202_CR137","doi-asserted-by":"publisher","unstructured":"Varjani SJ, Upasani VN. Critical review on biosurfactant analysis, purification and characterization using rhamnolipid as a model biosurfactant. Bioresource Technology. Elsevier Ltd; 2017. p. 389\u201397. https:\/\/doi.org\/10.1016\/j.biortech.2017.02.047.","DOI":"10.1016\/j.biortech.2017.02.047"},{"key":"4202_CR138","doi-asserted-by":"publisher","unstructured":"Wongsirichot P, Winterburn J. Recent advances in sophorolipid production: From laboratory to pilot scale and beyond. Journal of Cleaner Production. Elsevier Ltd; 2025. https:\/\/doi.org\/10.1016\/j.jclepro.2025.144898.","DOI":"10.1016\/j.jclepro.2025.144898"},{"key":"4202_CR139","doi-asserted-by":"publisher","unstructured":"Moutinho LF, Moura FR, Silvestre RC, Rom\u00e3o-Dumaresq AS. Microbial biosurfactants: A broad analysis of properties, applications, biosynthesis, and techno-economical assessment of rhamnolipid production. Biotechnol Prog. 2021;37(2). https:\/\/doi.org\/10.1002\/btpr.3093","DOI":"10.1002\/btpr.3093"},{"issue":"5","key":"4202_CR140","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/crj.13776","volume":"18","author":"T Merkl","year":"2024","unstructured":"Merkl T, Astapenko D, \u0160tichhauer R, \u0160afus A, Du\u0161ek T, Kotek J, et al. Exogenous surfactant for lung contusion causing ARDS: A systematic review of clinical and experimental reports. Clin Respir J. 2024;18(5):1\u20137. https:\/\/doi.org\/10.1111\/crj.13776.","journal-title":"Clin Respir J"},{"issue":"18","key":"4202_CR141","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/diagnostics13182964","volume":"13","author":"A Dushianthan","year":"2023","unstructured":"Dushianthan A, Grocott MPW, Murugan GS, Wilkinson TMA, Postle AD. Pulmonary Surfactant in Adult ARDS: Current Perspectives and Future Directions. Diagnostics. 2023;13(18):1\u201318. https:\/\/doi.org\/10.3390\/diagnostics13182964.","journal-title":"Diagnostics"},{"issue":"5","key":"4202_CR142","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1164\/rccm.2312021","volume":"169","author":"A Baritussio","year":"2004","unstructured":"Baritussio A. Lung Surfactant, Asthma, and Allergens. Am J Respir Crit Care Med. 2004;169(5):550\u20131. https:\/\/doi.org\/10.1164\/rccm.2312021.","journal-title":"Am J Respir Crit Care Med"},{"key":"4202_CR143","doi-asserted-by":"publisher","first-page":"S195","DOI":"10.33549\/PHYSIOLRES.934763","volume":"70","author":"A Calkovska","year":"2021","unstructured":"Calkovska A, Kolomaznik M, Calkovsky V. Alveolar Type II Cells and Pulmonary Surfactant in COVID-19 Era. Physiol Res. 2021;70:S195-208. https:\/\/doi.org\/10.33549\/PHYSIOLRES.934763.","journal-title":"Physiol Res"},{"issue":"4","key":"4202_CR144","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1152\/nips.01438.2003","volume":"18","author":"CB Daniels","year":"2003","unstructured":"Daniels CB, Orgeig S. Pulmonary surfactant: the key to the evolution of air breathing. News Physiol Sci. 2003;18(4):151\u20137. https:\/\/doi.org\/10.1152\/nips.01438.2003.","journal-title":"News Physiol Sci"},{"issue":"9","key":"4202_CR145","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1016\/j.bbamem.2017.04.019","volume":"1859","author":"A Hidalgo","year":"2017","unstructured":"Hidalgo A, Cruz A, P\u00e9rez-Gil J. Pulmonary surfactant and nanocarriers: toxicity versus combined nanomedical applications. Biochim Biophys Acta Biomembr. 2017;1859(9):1740\u20138. https:\/\/doi.org\/10.1016\/j.bbamem.2017.04.019.","journal-title":"Biochim Biophys Acta Biomembr"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-026-04202-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-026-04202-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-026-04202-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:54:46Z","timestamp":1791302086000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11095-026-04202-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":145,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["4202"],"URL":"https:\/\/doi.org\/10.1007\/s11095-026-04202-4","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"20 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}